Advisory Committee Chair
Advisory Committee Members
Date of Award
Degree Name by School
Master of Science (MS) College of Arts and Sciences
In breast cancer treatment, the presence of the estrogen receptor-alpha (ERα) plays an important role with hormonal-responsive drugs such as tamoxifen. ERα-negative breast cancers are more aggressive not only because of the increased uncontrollable growth but also because of the lack of target-directed treatments. Bioactive dietary components such as green tea polyphenols (GTPs) and sulforaphane (SFN, found in cruciferous vegetables) have been shown to have anti-cancer properties. In this study, we found that the dietary combination of a DNA methyltransferases (DNMTs) inhibitor, GTPs, and a histone deacetylase (HDAC) inhibitor, SFN, dose-dependently inhibited the proliferation of ERα-negative MDA-MB-231 human breast cancer cells. Combination GTPs and SFN treatment also epigenetically reactivated ERα expression in ERα-negative MDA-MB-231 breast cancer cells both at the gene and protein level. A combination of GTPs and SFN significantly inhibited DNMTs and HDAC activity, which is consistently associated with ERα promoter hypomethylation and hyperacetylation, respectively. In addition, a global decrease in methylation was also observed with combination GTPs and SFN treatment. Furthermore, treatment with tamoxifen in combination with GTPs and SFN significantly inhibited ERα-negative MDA-MB-231 breast cancer cellular proliferation and increased apoptosis of the cells. Collectively, this investigation provides a novel combination therapy of GTPs and SFN on hormonal refractory breast cancer with available drugs such as tamoxifen.
Patel, Shweta Naran, "Reactivation of estrogen receptor-α (ERα) by bioactive dietary compounds through epigenetic mechanisms in ERα-negative breast cancer cells" (2011). All ETDs from UAB. 2675.